Weight-loss injection pen boxes labelled Mounjaro, Wegovy, Ozempic and Zepbound stand with pens beside them
Pharma firms can charge far higher prices for GLP-1 drugs including Mounjaro, Wegovy and Ozempic than for diabetes treatments such as insulin. Photograph: ole999/Alamy
Pharma firms can charge far higher prices for GLP-1 drugs including Mounjaro, Wegovy and Ozempic than for diabetes treatments such as insulin. Photograph: ole999/Alamy
Pharma firms’ focus on weight-loss drugs could put insulin supply at risk, experts warn

GLP-1 products such as Ozempic and Mounjaro spread but many in poorer countries struggle to get basic diabetes treatment